跳至主要内容
临床试验/JPRN-UMIN000027983
JPRN-UMIN000027983已完成未知

Highly Active Antiretroviral Therapy and Cardiovascular Risk factor profiles of HIV-infected Subjects in Nigeria: a cross-sectional study - A risk prediction model for hypertension screening among HIV-positive Africans

niversity of Warwick Benue State University Teaching Hospital0 个研究点目标入组 400 人开始时间: 2017年7月10日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
400

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • HIV negative Age below 18 years Presence of opportunistic infections Pregnant or lactating Inadequate adherence to regular visits at HIV clinic No consent provided.

研究者

发起方
niversity of Warwick Benue State University Teaching Hospital

相似试验

已完成
不适用
Highly Active Antiretroviral Treatment (HAART) of Human Immunodeficiency Virus (HIV)-infection in a town in Cameroon: randomised controlled study to suggest which treatment starting point is most beneficial for the patientsHIV infectionInfections and InfestationsHIV
ISRCTN22114173Institute of Community Medicine, University of Tromsø (Norway)100
已完成
不适用
Impact of highly active anti-retroviral therapy (HAART) during pregnancy and breastfeeding on mother-to-child transmission (MTCT) and mother's healthHuman immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS)Infections and InfestationsHuman immunodeficiency virus (HIV)
ISRCTN71468401World Health Organization (WHO) (Switzerland)2,400
已完成
不适用
Highly active anti-retroviral therapy including nevirapine once daily versus twice daily after at least 12 weeks of nevirapine twice daily. A randomized, open, multicentre trial.
ISRCTN81305260Institute of Biomedical Investigations of Bellvitge (Institut d'Investigació Biomèdica de Bellvitge) (IDIBELL) (Spain)308
已完成
不适用
Directly Observed antiretroviral Therapy for people living with Human Immunodeficiency Virus (HIV) and Acquired ImmunDeficiency Syndrome (AIDS): a randomised controlled trial
ISRCTN48682427Ministry of Health (Brazil)
进行中(未招募)
1 期
Short pulse antiretroviral therapy at HIV seroconversion:A multi-centre randomised trial of therapeutic intervention at primary HIV-1 infection. Tratamiento antirretroviral en pulsos cortos en la seroconversión por el VIH: ensayo clínico aleatorizado, multicéntrico, de intervención terapéutica en la infección primaria por VIH-1. - SPARTACprimary HIV infection infección primaria por el VIHMedDRA version: 9.1 Level: LLT Classification code 10058427 Term: Primary HIV infection
EUCTR2004-000446-20-ESImperial College371
Highly Active Antiretroviral Therapy and... | 临床试验